Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 16, 2024

Outcomes of Therapeutic Heparin Use in Patients Without Critical Illness Hospitalized for COVID-19



Additional Info

Disclosure statements are available on the authors' profiles:

Therapeutic Heparin in non-ICU patients Hospitalized for COVID-19 in the ACTIV-4a Trial: Effect on 3 Month Symptoms and Quality of Life
Chest 2023 Nov 16;[EPub Ahead of Print], YY Greenstein, K Hubel, J Froess, SR Wisniewski, V Venugopal, YH Lai, JS Berger, SY Chang, C Colovos, F Shah, LZ Kornblith, PR Lawler, M Gaddh, RM Guerrero, W Nkemdirim, RD Lopes, HR Reynolds, JS Amigo, L Wahid, A Zahra, EC Goligher, R Zarychanski, E Leifer, DT Huang, MD Neal, JS Hochman, M Cushman, MN Gong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading